Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function

Angiogenesis

Volumn 3, Issue 3, 1999, Pages 271-280

  Cid, Maria C ^a   Esparza, Jordi ^a   Schnaper, H William ^b   Juan, Manel ^a   Yague, Jordi ^b   Grant, Derrick S ^c   Urbano Márquez, Alvaro ^a   Hoffman, Gary S ^d   Kleinman, Hynda K ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b NORTHWESTERN UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Endothelial cell; Estrogen; Integrins

Indexed keywords

EID: 0009733995     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009023329294     Document Type: Article

References (58)

1. Belchetz PE. Drug therapy: Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062-171.
2. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 1991; 325: 756-62.
3. Grodstein F, Stampfer MJ, Manson JE et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-61.
4. Hulley S, Grady D, Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998; 280: 605-51.
5. Beeson PB. Age and sex associations of 40 autoimmune diseases. JAMA 1994; 96: 457-62.
6. Sánchez-Guerrero J, Liang MH, Karlson EW et al. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995; 122: 430-2.
7. Ahmed SA, Pendhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985; 121: 531-51.
8. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 328-37.
9. Cid MC, Kleinman HK, Grant DS et al. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1 and vascular cell adhesion molecule type 1. J Clin Invest 1994; 93: 17-25.
10. Nabulsi AA, Folsom AR, White A et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069-75.
11. Riedel M, Rafflenbeul W, Lichtlen P. Ovarian sex steroids and atherosclerosis. Clin Invest 1993; 71: 406-12.
12. Stevenson JC, Crook D, Godsland IF et al. Hormone replacement therapy and the cardiovascular system. Non lipid effects. Drugs 1994; 47: 35-41.
13. Walsh BW, Schiff I, Rosner B et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-204.
14. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996; 10: 615-24.
15. Ponce ML, Cid MC, Kim-Schulze S et al. Role of estrogens in endothelial cell behavior. In Rubany G, Kauffman R (eds): Estrogens and the Vessel Wall. Amsterdam, The Netherlands: Harwood Academic Publications 1998; 63-72.
16. Caulin-Glaser T, Sessa WC, Bender JR. Modulation of cellular adhesion molecules and endothelial nitric oxide synthase by estrogen. In Rubany G, Kauffman R (eds): Estrogens and the Vessel Wall. Amsterdam, The Netherlands: Harwood Academic Publications 1998; 73-90.
17. Iafrati MD, Karas RH, Aronovitz M et al. Estrogen inhibits the vascular injury response in estrogen receptor a-deficient mice. Nat Med 1997; 3: 545-8.
18. Brandi ML, Crescioli C, Tanini A et al. Bone endothelial cells as estrogen targets. Calcif Tissue Int 1993; 53: 312-7.
19. Kim-Schulze S, McGowan K, Hubchak SC et al. Expression of a functional estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996; 94: 1402-7.
20. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol 1995; 268: H377-83.
21. Williams JK, Hinore EK, Wasburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994; 24: 1757-61.
22. Gilligan DM, Badar DM, Panza JA et al. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-91.
23. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-51.
24. Gilligan DM, Badar DM, Panza JA et al. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995; 75: 264-8.
25. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936-41.
26. Rels SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acuitely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
27. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than male rabbits: Implications for athereosclerosis. Proc Natl Acad Sci USA 1994; 91: 5212-6.
28. Weiner CP, Lizasoain I, Baylis SA et al. Induction of calcium-dependent nitric oxide synthase by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-6.
29. Venema RC, Nishida K, Alexqander RW. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1994; 1218: 413-20.
30. Morales DE, McGowan KA, Grant DS et al. Estrogens promote angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995; 91: 755-63.
31. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11-25.
32. Lampugnani MG, Resnati M, Dejana E, Marchisio PC. The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol 1991; 112: 479-90.
33. Gamble JR. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J Cell Biol 1993; 4: 931-43.
34. Grant DS, Tashiro KI, Seguí-Real B et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989; 58: 933-43.
35. Juliano RL, Haskill S. Signal transduction from extracellular matrix. J Cell Biol 1993; 120: 577-85.
36. Clark EA, Brugge JS. Integrins and signals transduction pathways: The road taken. Science 1995; 268: 233-9.
37. Luscinskas FW, Lawler J. Integrins as dynamic regulators of vascular function. FASEB J 1994; 9: 929-38.
38. Kleinman HK. Isolation and characterization of type IV procollagen, laminin and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982; 24: 6188-93.
39. Hogervorst F, Kuikman I, van Kessel AG, Sonnenberg A. Molecular cloning of the human alpha 6 integrin subunit. Alternative splicing of alpha 6 mRNA and chromosomal localization of the alpha 6 and beta 4 genes. Eur J Biochem 1991; 199: 425-33.
40. Young IT. Proof without prejudice: Use of Kolmogorov-Smirnov test for the analysis of histograms from flow system and other sources. J Histochem Cytochem 1977; 25: 935-41.
41. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-99.
42. Mecham RP. Receptors for laminin on mammalian cells. FASEB J 1991; 5: 2538-46.
43. Yanagisawa-Miwa A, Uchida Y, Nakamura F et al. Salvage of infrared myocardium by angiogenic action of basic fibroblast grown factor. Science 1992; 257: 1401-3.
44. Defilippi P, van Hinsberg V, Bertolotto A et al. Differential distribution and modulation of expression of α1β1 integrin on human endothelial cells. J Cell Biol 1991; 114: 855-63.
45. Defilippi P, Truffa G, Stefanuto G et al. Tumor necrosis factor a and interferon-γ modulate the expression of the vitronectin receptor (integrin β3) in human endothelial cells. J Biol Chem 1991; 266: 7638-45.
46. Defilippi P, Silengo L, Tarone G. α6β1 integrin (laminin receptor) is down-regulated by tumor necrosis factor α and interleukin-1β in human endothelial cells. J Biol Chem 1992; 267: 18303-7.
47. Basson CT, Kocher O, Basson MC et al. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGFβ 1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992; 153: 118-28.
48. Enenstein J, Waleh NS, Kramer RH. Basic FGF and TGFβ differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992; 203: 499-503.
49. Klein S, Giancotti FG, Presta M et al. Basic fibroblast growth factor modulated integrin expression in microvascular endothelial cells. Mol Biol Cell 1993; 4: 973-82.
50. Albuquerque ML, Akiyama SK, Schnaper HW. Basic fibroblast growth factor release by human coronary artery endothelial cells is enhanced by matrix proteins, 17β-estradiol, and a PKC signaling pathway. Exp Cell Res 1998; 245: 163-9.
51. Kim-Schulze S, Lowe WL, Schnaper HW. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor. Circulation 1998; 98: 413-21.
52. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-32.
53. Zutter MM, Santoro SA, Painter AS et al. The human alpha 2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J Biol Chem 1994; 269: 463-9.
54. Horwitz KB, McGuire WL. Nuclear mechanisms of estrogen action. J Biol Chem 1978; 253: 8185-91.
55. Sukovich DA, Mukherjee R, Benfield PA. A novel cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Mol Cell Biol 1994; 14: 7134-43.
56. Li CF, Ross FP, Cao X, Teitelbaum SL. Estrogen enhances alpha v beta 3 integrin expression by avian osteoclast precursors via stabilization of beta 3 integrin mRNA. Mol Endocrinol 1995; 9: 805-13.
57. Morley P, Whitfield JF, Vanderhyden BC et al. A new nongenomic estrogen action: The rapid release of intracellular calcium. Endocrinology 1992; 131: 1305-12.
58. Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 1994; 91: 8517-21.